Tempo Therapeutics: Funding, Investors & Team (Sep 2026)
Tempo Therapeutics creates materials that are designed for regenerative medicine, with a focus on being immune-resistant, minimally invasive, and precisely engineered. These materials support the growth of synthetic tissue hybrids in various parts of the body, such as the skin, bones, heart, and brain, while avoiding the usual immune rejection response from the host.
Tempo Therapeutics has raised $26.5M across 3 funding rounds on record, the most recent an undisclosed round of $14.5M announced in Sep 2026.
That round is above the $5.0M median round size for Health Care companies tracked on FundedIQ over the last two years.
Tempo Therapeutics Company Profile and Key Stats
Latest funding round on record: Sep 2026.
Tempo Therapeutics Funding Rounds
1 of 3 rounds was announced without a disclosed amount and is excluded from the total.
Tempo Therapeutics raised $12.0M in an undisclosed round announced in Mar 2024.
6 months later, an undisclosed round was announced in Sep 2024 with no disclosed amount.
2 years later, an undisclosed round of $14.5M was announced in Sep 2026.
Tempo Therapeutics Investors
8 investors are recorded in total; the 6 named above are those the record identifies.
Tempo Therapeutics Founders and Leadership Team
Contact details for the Tempo Therapeutics team: 2 of 2 have an email address on file, 2 have a LinkedIn profile.
Start 14-day free trial →Tempo Therapeutics Funding Compared to Other Health Care Startups
Tempo Therapeutics' latest round of $14.5M is above the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Tempo Therapeutics in Health Care and San Diego
Companies Similar to Tempo Therapeutics
Vibronix was established by Dr. Ji-Xin Cheng and Dr. Pu Wang at Purdue University with the goal of offering…
People with chronic diseases can live their best lives thanks to Vheda Health. We concentrate on three areas…
Thyme Care is an oncology solution that integrates patients and providers, working with health plans to…
https://metriport.com
There are too many reasons why Healthcare is unaffordable in the U.S, but one of the largest is waste. Up to…
Serif Health provides healthcare price intelligence and contract management solution.
Switchboard Health provides virtual care solutions to payers, health systems, employers, and at-risk…
Astek Diagnostics has designed a system that helps doctors choose the right antibiotics for patients…
TECLens is developing a crosslinking technology that can effectively address vision problems in both healthy…
Healthcare Shares operates as a crowdfunding portal for the transformative medical innovations of the future.
Gradient Health collaborates with medical data providers worldwide to assemble diseases and conditions for AI…
Kalivir designs safe and potent oncolytic product candidates across multiple tumor types. Kalivir’s…
Tempo Therapeutics Funding FAQs
What does Tempo Therapeutics do?
Tempo Therapeutics creates materials that are designed for regenerative medicine, with a focus on being immune-resistant, minimally invasive, and precisely engineered. These materials support the growth of synthetic tissue hybrids in various parts of the body, such as the skin, bones, heart, and brain, while avoiding the usual immune rejection response from the host.
How much funding has Tempo Therapeutics raised?
Tempo Therapeutics has raised $26.5M across 3 rounds on record. The most recent is an undisclosed round of $14.5M announced in Sep 2026.
When did Tempo Therapeutics last raise funding?
Tempo Therapeutics' most recent funding round on record is an undisclosed round of $14.5M, announced in Sep 2026.
Who has invested in Tempo Therapeutics?
Investors on record for Tempo Therapeutics include National Science Foundation, Johnson & Johnson Services, Inc., Gideon Strategic Partners, Mesa Verde Venture Partners, YK Bioventures. FundedIQ records 8 investors in total.
Who founded Tempo Therapeutics?
FundedIQ lists Philip Scumpia (Cofounder and VP of Medical Affairs), Westbrook Weaver (Founder) at Tempo Therapeutics.
Where is Tempo Therapeutics headquartered?
Tempo Therapeutics is based in San Diego, California, United States.
How many employees does Tempo Therapeutics have?
Tempo Therapeutics is in the 11-50 employee band.
When was Tempo Therapeutics founded?
Tempo Therapeutics was founded in 2014.
How does Tempo Therapeutics' funding compare to other Health Care startups?
Tempo Therapeutics' latest round of $14.5M is above the $5.0M median round size for Health Care companies on FundedIQ across 3,654 tracked companies over the last two years.
About FundedIQ's Tempo Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Tempo Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.